Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?

A major challenge of obesity therapy is to sustain clinically relevant weight loss over time. Achieving this goal likely requires both reducing daily caloric intake and increasing caloric expenditure. Over the past decade, advances in pharmaceutical engineering of ligands targeting G protein-coupled...

Descripción completa

Detalles Bibliográficos
Autores principales: Conceição-Furber, Ellen, Coskun, Tamer, Sloop, Kyle W., Samms, Ricardo J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081793/
https://www.ncbi.nlm.nih.gov/pubmed/35547006
http://dx.doi.org/10.3389/fendo.2022.868037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081793/
https://www.ncbi.nlm.nih.gov/pubmed/35547006
http://dx.doi.org/10.3389/fendo.2022.868037

Ejemplares similares